FDA Import Refusal AEK-1205232-8/11/1 — MSD PHARMACEUTICALS PVT LTD
The FDA refused shipment AEK-1205232-8/11/1 from MSD PHARMACEUTICALS PVT LTD (India) on Jun 7, 2022. The refused product falls under Drugs and Biologics — SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC). Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jun 7, 2022
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PCY68 SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
- Charges
- 118,3280,75